Targeted anti-toxin therapeutic shows promise against C. difficile infections

In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for Sick Children (SickKids) have uncovered how the body’s bile acids bind to block C. diff’s most dangerous toxin.

Continue Reading

News Source: medicalxpress.com